bibliographic resource 560043 [br/560043]
https://w3id.org/oc/corpus/br/560043
- is a
-
- title
-
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-